{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:19:58Z","timestamp":1789885198800,"version":"4.0.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The Endocrine Society Guidelines and recent reviews of adrenal insufficiency (AI) recommend a daily glucocorticoid replacement dose of 15 to 25 mg with a midpoint of 20 mg of hydrocortisone (HC) (alternatively 3 to 5 mg prednisolone) in divided doses in otherwise healthy individuals with AI. In contrast, a daily glucocorticoid replacement dose of 4.3 to 26 mg\/d HC with a midpoint of 15 mg\/d is predicted from current measurements of daily cortisol production rates and oral HC bioavailability. The higher HC doses recommended in the current guidelines may result in glucocorticoid overtreatment of some AI patients and associated long-term adverse outcomes. A titration method for determination of the individual patient\u2019s daily glucocorticoid replacement dose and the impact of lower doses are reviewed. Future related research questions are identified.<\/jats:p>","DOI":"10.3389\/fendo.2022.897211","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:27:31Z","timestamp":1656462451000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Daily Glucocorticoid Replacement Dose in Adrenal Insufficiency, a Mini Review"],"prefix":"10.3389","volume":"13","author":[{"given":"Celina M.","family":"Caetano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl D.","family":"Malchoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00136-7","article-title":"Adrenal Insufficiency","volume":"397","author":"Husebye","year":"2021","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030440","article-title":"Association of 24-Hour Cortisol Production Rates, Cortisol-Binding Globulin, and Plasma-Free Cortisol Levels With Body Composition, Leptin Levels, and Aging in Adult Men and Women","volume":"89","author":"Purnell","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.2.236","article-title":"Corticosteroid Supplementation for Adrenal Insufficiency","volume":"287","author":"Coursin","year":"2002","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1210\/jcem-72-1-39","article-title":"Daily Cortisol Production Rate in Man Determined by Stable Isotope Dilution\/Mass Spectrometry","volume":"72","author":"Esteban","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/0039-128X(90)90103-I","article-title":"Cortisol Production Rates Measured by Liquid Chromatography\/Mass Spectrometry","volume":"55","author":"Esteban","year":"1990","journal-title":"Steroids"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.76.6.8501158","article-title":"Estimation of Daily Cortisol Production and Clearance Rates in Normal Pubertal Males by Deconvolution Analysis","volume":"76","author":"Kerrigan","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1991.tb01906.x","article-title":"Pharmacokinetics and Oral Bioavailability of Hydrocortisone","volume":"31","author":"Derendorf","year":"1991","journal-title":"J Clin Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"001","DOI":"10.4172\/jbb.1000365","article-title":"Bioavailability of Oral Hydrocortisone Corrected for Binding Proteins and Measured by LC-MS\/MS Using Serum Cortisol and Salivary Cortisone","volume":"10","author":"Johnson","year":"2018","journal-title":"J Bioequivalence Bioavailab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02106.x","article-title":"Weight-Related Dosing, Timing and Monitoring Hydrocortisone Replacement Therapy in Patients With Adrenal Insufficiency","volume":"61","author":"Mah","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01146-y","article-title":"Towards the Tailoring of Glucocorticoid Replacement in Adrenal Insufficiency: The Italian Society of Endocrinology Expert Opinion","volume":"43","author":"Isidori","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/cen.12603","article-title":"Adrenal Insufficiency: Review of Clinical Outcomes With Current Glucocorticoid Replacement Therapy","volume":"82","author":"Johannsson","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B13","article-title":"Adrenal Insufficiency","volume-title":"Current Therapy in Endocrinology and Metabolism","author":"Malchoff","year":"1997"},{"key":"B14","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1365-2265.2008.03340.x","article-title":"Increased Death Risk and Altered Cancer Incidence Pattern in Patients With Isolated or Combined Autoimmune Primary Adrenocortical Insufficiency","volume":"69","author":"Bensing","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0076","article-title":"Premature Mortality in Patients With Addison's Disease: A Population-Based Study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0524","article-title":"The Impact of Glucocorticoid Replacement Regimens on Metabolic Outcome and Comorbidity in Hypopituitary Patients","volume":"91","author":"Filipsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors: A Cross-Sectional Multicenter Study","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-021-00252-7","article-title":"Adrenal Insufficiency","volume":"7","author":"Hahner","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B19","doi-asserted-by":"publisher","first-page":"bvaa145","DOI":"10.1210\/jendso\/bvaa145","article-title":"Empiric Determination of the Daily Glucocorticoid Replacement Dose in Adrenal Insufficiency","volume":"4","author":"Caetano","year":"2020","journal-title":"J Endocr Soc"},{"key":"B20","article-title":"Adrenocorticosteroids & Adrenocortical Antagonists","volume-title":"Basic and Clinical Pharmacology","author":"Chrousos","year":"2011"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1988.tb03105.x","article-title":"Relative and Absolute Bioavailability of Prednisone and Prednisolone After Separate Oral and Intravenous Doses","volume":"28","author":"Ferry","year":"1988","journal-title":"J Clin Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(77)90233-9","article-title":"Potency and Duration of Action of Glucocorticoids","volume":"63","author":"Meikle","year":"1977","journal-title":"Am J Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27302004000500017","article-title":"One-Year Clinical Evaluation of Single Morning Dose Prednisolone Therapy for 21-Hydroxylase Deficiency","volume":"48","author":"Caldato","year":"2004","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1926","article-title":"Improved Cortisol Exposure-Time Profile and Outcome in Patients With Adrenal Insufficiency: A Prospective Randomized Trial of a Novel Hydrocortisone Dual-Release Formulation","volume":"97","author":"Johannsson","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13141","article-title":"ACTH and Gonadotropin Deficiencies Predict Mortality in Patients Treated for Nonfunctioning Pituitary Adenoma: Long-Term Follow-Up of 519 Patients in Two Large European Centres","volume":"85","author":"O'Reilly","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2432","article-title":"Glucocorticoid Replacement and Mortality in Patients With Nonfunctioning Pituitary Adenoma","volume":"97","author":"Zueger","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0340","article-title":"Higher Glucocorticoid Replacement Doses are Associated With Increased Mortality in Patients With Pituitary Adenoma","volume":"177","author":"Hammarstrand","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb02928.x","article-title":"Cardiovascular Function and Glucocorticoid Replacement in Patients With Hypopituitarism","volume":"43","author":"Dunne","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-008-0126-2","article-title":"Correction of Cortisol Overreplacement Ameliorates Morbidities in Patients With Hypopituitarism: A Pilot Study","volume":"11","author":"Danilowicz","year":"2008","journal-title":"Pituitary"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4305","article-title":"Acute Effect of Increasing Glucocorticoid Replacement Dose on Cardiovascular Risk and Insulin Sensitivity in Patients With Adrenocorticotrophin Deficiency","volume":"99","author":"Petersons","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-1187","article-title":"Low-Dose Hydrocortisone Replacement is Associated With Improved Arterial Stiffness Index and Blood Pressure Dynamics in Severely Adrenocorticotrophin-Deficient Hypopituitary Male Patients","volume":"174","author":"Behan","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0596","article-title":"Low-Dose Hydrocortisone Replacement Therapy Is Associated With Improved Bone Remodelling Balance in Hypopituitary Male Patients","volume":"170","author":"Behan","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00434","article-title":"Glycometabolic Alterations in Secondary Adrenal Insufficiency: Does Replacement Therapy Play a Role","volume":"9","author":"Graziadio","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02473.x","article-title":"Quality of Glucocorticoid Replacement in Adrenal Insufficiency: Clinical Assessment vs. Timed Serum Cortisol Measurements","volume":"64","author":"Arlt","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02343-z","article-title":"Fertility and Pregnancy in Women With Primary Adrenal Insufficiency","volume":"70","author":"Bensing","year":"2020","journal-title":"Endocrine"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa266","article-title":"Current Management and Outcome of Pregnancies in Women With Adrenal Insufficiency: Experience From a Multicenter Survey","volume":"105","author":"Bothou","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EJE-20-0052","article-title":"MANAGEMENT OF ENDOCRINE DISEASE Disease Burden and Treatment Challenges in Patients With Both Addison's Disease and Type 1 Diabetes Mellitus","volume":"183","author":"Chantzichristos","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2008.09.010","article-title":"Novel Strategies for Hydrocortisone Replacement","volume":"23","author":"Debono","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0257","article-title":"Prednisolone has the Same Cardiovascular Risk Profile as Hydrocortisone in Glucocorticoid Replacement","volume":"6","author":"Smith","year":"2017","journal-title":"Endocr Connect"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13999","article-title":"Improving Glucocorticoid Replacement Profiles in Adrenal Insufficiency","volume":"91","author":"Choudhury","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1373\/jalm.2016.020206","article-title":"Prednisolone Replacement Therapy Mimics the Circadian Rhythm More Closely Than Other Glucocorticoids","volume":"1","author":"Williams","year":"2016","journal-title":"J Appl Lab Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1687-9856-2011-5","article-title":"Early Onset Obesity and Adrenal Insufficiency Associated With a Homozygous POMC Mutation","volume":"2011","author":"Mendiratta","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","article-title":"Craniopharyngioma","volume":"5","author":"Muller","year":"2019","journal-title":"Nat Rev Dis Primers"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.897211\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:27:39Z","timestamp":1656462459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.897211\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":43,"alternative-id":["10.3389\/fendo.2022.897211"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.897211","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"article-number":"897211"}}